PE20000939A1 - Formulaciones de fsh y variantes de fsh, productos y metodos - Google Patents
Formulaciones de fsh y variantes de fsh, productos y metodosInfo
- Publication number
- PE20000939A1 PE20000939A1 PE1999000738A PE00073899A PE20000939A1 PE 20000939 A1 PE20000939 A1 PE 20000939A1 PE 1999000738 A PE1999000738 A PE 1999000738A PE 00073899 A PE00073899 A PE 00073899A PE 20000939 A1 PE20000939 A1 PE 20000939A1
- Authority
- PE
- Peru
- Prior art keywords
- fsh
- cresol
- amino acids
- formulation
- variant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 3
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 239000004288 Sodium dehydroacetate Substances 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960002242 chlorocresol Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 abstract 1
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 abstract 1
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 abstract 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 229940079839 sodium dehydroacetate Drugs 0.000 abstract 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 abstract 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA FORMULACION QUE COMPRENDE a)HORMONA FOLICULO ESTIMULANTE (FSH); QUE CONTIENE UNA SUBUNIDAD ALFA DE 92 AMINOACIDOS o 96 AMINOACIDOS Y UNA SUBUNIDAD BETA DE 111 o 109 o 110 o 108 AMINOACIDOS O UNA VARIANTE DE FSH QUE COMPRENDE POR LO MENOS 90% DE DIMEROS DE FSH, QUE SE UNEN MEDIANTE ENLACES NO COVALENTES; UTILIZANDOSE DE 1 µg/ml A 50 mg/ml; b)UN PRESERVANTE SELECCIONADO DE FENOL, m-CRESOL, p-CRESOL, o-CRESOL, CLOROCRESOL, ALCOHOL BENCILICO, ALQUILPARABENO, CLORURO DE BENZALCONIO, CLORURO DE BENCENTONIO, DEHIDROACETATO DE SODIO Y TIMEROSAL; c)UN AGENTE DE ISOTONICIDAD; d)UN AMORTIGUADOR DE FOSFATO QUE INCLUYE UNA SOLUCION SALINA. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE LA FORMULACION PRESERVADA, ESTABLE O PURIFICADA DE FSH O VARIANTE DE FSH. LA FORMULACION PUEDE SER UTIL PARA INCREMENTAR LOS NIVELES DE FSH Y PARA EL TRATAMIENTO DE LA INFERTILIDAD
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9390698P | 1998-07-23 | 1998-07-23 | |
| US9461198P | 1998-07-30 | 1998-07-30 | |
| US9476798P | 1998-07-31 | 1998-07-31 | |
| US9871198P | 1998-09-01 | 1998-09-01 | |
| US10069698P | 1998-09-17 | 1998-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000939A1 true PE20000939A1 (es) | 2000-09-20 |
Family
ID=27536687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000738A PE20000939A1 (es) | 1998-07-23 | 1999-07-22 | Formulaciones de fsh y variantes de fsh, productos y metodos |
Country Status (24)
| Country | Link |
|---|---|
| EP (2) | EP0974359B2 (es) |
| JP (1) | JP4719357B2 (es) |
| KR (1) | KR20010083126A (es) |
| CN (1) | CN1309567A (es) |
| AR (1) | AR020618A1 (es) |
| AT (2) | ATE228850T1 (es) |
| AU (1) | AU776823B2 (es) |
| BR (1) | BR9912243A (es) |
| CA (1) | CA2335340C (es) |
| CO (1) | CO5090905A1 (es) |
| DE (2) | DE69904262T3 (es) |
| DK (1) | DK0974359T4 (es) |
| ES (2) | ES2183486T3 (es) |
| HK (1) | HK1026615A1 (es) |
| ID (1) | ID28747A (es) |
| IL (1) | IL140984A0 (es) |
| MY (1) | MY135913A (es) |
| NO (1) | NO20010326L (es) |
| NZ (1) | NZ508874A (es) |
| PE (1) | PE20000939A1 (es) |
| PL (1) | PL346127A1 (es) |
| PT (1) | PT974359E (es) |
| SI (1) | SI0974359T1 (es) |
| WO (1) | WO2000004913A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6414123B1 (en) * | 1997-10-21 | 2002-07-02 | Vitro Diagnostics, Inc. | Method for purifying FSH |
| US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| AU779869B2 (en) | 1999-04-13 | 2005-02-17 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility |
| TW201002201A (en) | 2001-03-01 | 2010-01-16 | Lonza Ag | Preservative blends containing quaternary ammonium compounds |
| AR043972A1 (es) * | 2003-04-02 | 2005-08-17 | Ares Trading Sa | Formulaciones farmaceuticas de fsh y lh |
| EP1638595B1 (en) | 2003-06-20 | 2013-03-20 | Ares Trading S.A. | Freeze-dried fsh / lh formulations |
| KR101105871B1 (ko) * | 2005-09-27 | 2012-01-16 | 주식회사 엘지생명과학 | 인 난포자극호르몬의 안정한 용액 제형 |
| US8518881B2 (en) | 2007-02-08 | 2013-08-27 | Aspenbio Pharma, Inc. | Methods for inducing superovulation in ungulates |
| UA103598C2 (uk) | 2007-06-28 | 2013-11-11 | Биодженерикс Аг | Клон клітин, що продукують fsh |
| JP5551601B2 (ja) * | 2007-11-01 | 2014-07-16 | メルク セローノ ソシエテ アノニム | Ｌｈ液体調製物 |
| WO2009098318A1 (en) * | 2008-02-08 | 2009-08-13 | Biogenerix Ag | Liquid formulation of fsh |
| CN102309745B (zh) * | 2008-09-17 | 2013-05-08 | 上海天伟生物制药有限公司 | 一种卵泡刺激素冻干针剂 |
| WO2010149214A1 (de) | 2009-06-24 | 2010-12-29 | Tecpharma Licensing Ag | Verabreichungsgerät mit priming funktion |
| EP2325194A1 (en) | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Process for the purification of glycoproteins |
| WO2011076280A1 (de) | 2009-12-23 | 2011-06-30 | Tecpharma Licensing Ag | Injektionsvorrichtung mit einer nadelschutzhülse |
| WO2011076281A1 (de) | 2009-12-23 | 2011-06-30 | Tecpharma Licensing Ag | Entfernen einer nadelschutzkappe von einer nadel |
| EP2534650B1 (en) | 2010-02-11 | 2016-07-13 | Finox Ag | Injection training dummy |
| CN102821782B (zh) * | 2010-02-12 | 2015-07-15 | 印塔斯生物制药有限公司 | 促卵泡激素的液体配制品 |
| EP2417982A1 (en) | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
| WO2012142961A1 (zh) * | 2011-04-22 | 2012-10-26 | 上海天伟生物制药有限公司 | 一种低溶剂残留的糖蛋白组合物及其制备方法和用途 |
| JP5750471B2 (ja) * | 2013-05-22 | 2015-07-22 | Ｊｃｒファーマ株式会社 | 組換え体ヒトｆｓｈの製造方法 |
| CN103539860B (zh) * | 2013-11-01 | 2014-12-03 | 广州优联康医药科技有限公司 | 一种长效重组人促卵泡激素融合蛋白 |
| CN103539861B (zh) * | 2013-11-01 | 2015-02-18 | 广州联康生物科技有限公司 | 长效重组人促卵泡激素融合蛋白 |
| CN103554269B (zh) * | 2013-11-01 | 2015-02-11 | 广州联康生物科技有限公司 | 重组猪促卵泡激素融合蛋白 |
| CN105658201A (zh) * | 2013-11-12 | 2016-06-08 | 卡迪拉保健有限公司 | 促性腺激素的制剂 |
| MX2018002921A (es) * | 2015-09-17 | 2018-12-10 | Glycotope Gmbh | Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada. |
| GB201603280D0 (en) * | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB839300A (en) * | 1957-09-05 | 1960-06-29 | Organon Labor Ltd | Adrenocorticotropic hormone preparations and process for making same |
| US4659696A (en) † | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
| US5162306A (en) * | 1987-01-23 | 1992-11-10 | Donaldson Lloyd E | Composition and method for producing superovulation in mammals |
| IT1206302B (it) * | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| FR2623715B1 (fr) * | 1987-11-26 | 1990-12-21 | Lafon Labor | Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite |
| US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| AU686567C (en) * | 1992-07-31 | 2002-08-08 | Genentech Inc. | Human growth hormone aqueous formulation |
| US5661125A (en) * | 1992-08-06 | 1997-08-26 | Amgen, Inc. | Stable and preserved erythropoietin compositions |
| DE69508985T2 (de) † | 1994-02-21 | 1999-08-19 | Takeda Chemical Industries Ltd | Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe |
| TW426523B (en) * | 1995-04-06 | 2001-03-21 | Hoffmann La Roche | Interferon solution |
| AU721112B2 (en) * | 1995-11-07 | 2000-06-22 | Genentech Inc. | Stabilizing formulation for NGF |
| GB2317010A (en) * | 1996-09-04 | 1998-03-11 | Eev Ltd | Gas sensor detecting only non-reflected light |
| TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| US6287587B2 (en) † | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
| ZA9811127B (en) * | 1997-12-09 | 2000-07-11 | Lilly Co Eli | Stabilized teriparatide solutions. |
| JP2000151148A (ja) * | 1998-11-13 | 2000-05-30 | Mitsumi Electric Co Ltd | 携帯用電子機器のコード接続構造 |
-
1999
- 1999-07-15 JP JP2000560906A patent/JP4719357B2/ja not_active Expired - Lifetime
- 1999-07-15 PL PL99346127A patent/PL346127A1/xx not_active Application Discontinuation
- 1999-07-15 CN CN99808813A patent/CN1309567A/zh active Pending
- 1999-07-15 WO PCT/US1999/016031 patent/WO2000004913A1/en not_active Application Discontinuation
- 1999-07-15 ID IDW20010141A patent/ID28747A/id unknown
- 1999-07-15 AU AU49980/99A patent/AU776823B2/en not_active Expired
- 1999-07-15 KR KR1020017000781A patent/KR20010083126A/ko not_active Application Discontinuation
- 1999-07-15 BR BR9912243-0A patent/BR9912243A/pt not_active IP Right Cessation
- 1999-07-15 NZ NZ508874A patent/NZ508874A/xx unknown
- 1999-07-15 CA CA2335340A patent/CA2335340C/en not_active Expired - Lifetime
- 1999-07-15 IL IL14098499A patent/IL140984A0/xx unknown
- 1999-07-16 SI SI9930156T patent/SI0974359T1/xx unknown
- 1999-07-16 DK DK99305664T patent/DK0974359T4/da active
- 1999-07-16 AT AT99305664T patent/ATE228850T1/de active
- 1999-07-16 DE DE69904262T patent/DE69904262T3/de not_active Expired - Lifetime
- 1999-07-16 PT PT99305664T patent/PT974359E/pt unknown
- 1999-07-16 DE DE69928296T patent/DE69928296T2/de not_active Expired - Lifetime
- 1999-07-16 ES ES99305664T patent/ES2183486T3/es not_active Expired - Lifetime
- 1999-07-16 EP EP99305664A patent/EP0974359B2/en not_active Expired - Lifetime
- 1999-07-16 EP EP01130213A patent/EP1188444B1/en not_active Revoked
- 1999-07-16 AT AT01130213T patent/ATE308990T1/de active
- 1999-07-16 ES ES01130213T patent/ES2250290T3/es not_active Expired - Lifetime
- 1999-07-21 CO CO99045916A patent/CO5090905A1/es unknown
- 1999-07-22 AR ARP990103624A patent/AR020618A1/es not_active Application Discontinuation
- 1999-07-22 PE PE1999000738A patent/PE20000939A1/es not_active Application Discontinuation
- 1999-07-22 MY MYPI99003089A patent/MY135913A/en unknown
-
2000
- 2000-07-24 HK HK00104578A patent/HK1026615A1/xx not_active IP Right Cessation
-
2001
- 2001-01-19 NO NO20010326A patent/NO20010326L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000939A1 (es) | Formulaciones de fsh y variantes de fsh, productos y metodos | |
| AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
| CO4950523A1 (es) | Formulaciones de proteina c activada | |
| CO5690564A2 (es) | Medicamento para tratar tejido de miocardio infartado que comprende mioblastos oseos de mamiferos geneticamente modoficados para expresar la proteina sdf-1 de mamifero | |
| CO5160320A1 (es) | Metodos y composiciones para la prevencion de tolerancia a medicamentos das. | |
| JP2002521342A5 (es) | ||
| PE58998A1 (es) | Terapia combinada para la osteoporosis | |
| BR9813474A (pt) | Processo para intensificar uma absorção pelo animal de pelo menos um composto lipofìlico, e, composição | |
| EA199801086A1 (ru) | Неводные медицинские средства для очистки толстой кишки | |
| CO5160262A1 (es) | Formulaciones farmaceuticas de liberacion controlada | |
| ES2062065T3 (es) | Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente. | |
| EP0289314A3 (en) | Use of igf-ii in the treatment of bone disorders | |
| NL300243I2 (nl) | Proteïne formuleringen. | |
| BR9607965A (pt) | Composto composição farmacêutica e processo para tratar uma doença parasítica em um mamífero | |
| AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
| AU2002231889A1 (en) | Halogenated composition, method for preparing same and uses thereof | |
| ES2050435T3 (es) | Una preparacion medicinal o vacuna y composicion inmunogenica peptida, un metodo de inmunizacion de un mamifero contra lhrh, y un metodo para mejorar la calidad carnica del ganado porcuno. | |
| ES2094702B1 (es) | Composiciones farmaceuticas para la prevencion y el tratamiento de enfermedades cancerosas y procedimiento para su preparacion. | |
| ES2103733T3 (es) | Procedimiento para combatir el piojo de los peces. | |
| ES2163631T3 (es) | Un peptido mejorado, composicion inmunogenica y vacuna o preparacion medica, un procedimiento para inmunizar a los animales contra la hormona lhrh, analogos del peptido lhrh repetidos en tandem y su uso como vacuna. | |
| AR024959A1 (es) | Una composicion farmaceutica liquida basada en paracetamol | |
| WO2001045684A3 (en) | Formulations of adenosine a1 agonists | |
| PE117199A1 (es) | Formulaciones parasiticidas | |
| KR970706802A (ko) | 저압-타정된 발포 제제(low-pressure tableted effervescent preparation) | |
| MC1930A1 (fr) | Produit antiviral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |